12^th International Conference on Clinical Research & Clinical Trials November 28-29, 2022 Zurich, Switzerland

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University with MD. In 1985, maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Acade-my of Medical Sciences. In 2001, maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1989, worked as a Post Doc Res Associate, for Inst of Medical Enzymology; and then Koltzov Institute of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was a Head of the Lab of Immunology, Helmholtz Eye Res Institute in Moscow. In 1989-1990, was trained at the NEI, NIH, Bethesda, MD, USA, and Wills Eye Hospital, Philadelphia, USA, as well as at some of the British universities on the invitation of the Royal Society for Immunology. From 1995 through 2004, was a Director of the Dept for Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, was an Executive Secretary-in-Chief of the Editorial Board, Biomedical Science, an int journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is: Professor and Chair, Dept for Personalized Medicine, Precision Nutriciology & Biodesign, Moscow State University for Nutrition Industry, Moscow, Russia

Clinical Immunology, Human pathology, Nutrition

Donato Bonifazi, Mr (MEcon), Chief Executive Officer of Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) and its Branch Office in Tirana; Legal Representative of TEDDY European Network of Excellence for Paediatric Clinical Research.In particular, he is President of AICRO (Italian Association of CROs), chair of the Events and Training Working Group and member of the Paediatric Working Group of EUCROF (European CRO Federation), Member of Working Groups at Enpr-EMA (Young Patients Advisory Groups; Trial Readiness and Preparedness; Public-private partnership).

He is strongly involved in the enhancement of clinical research and member of several Associations and working groups.

Vesna Popovska has graduated from medical school in 1988, and completed her residency in Ob/Gyn in 1998 in Skopje, Macedonia. She moved to Canada in 1999 and joined the Division of Maternal Fetal Medicine at BC Women’s Hospital, where she established and lead the MFM Research Program. In 2005, she was recruited by the Neurosciences Program at BC Children’s Hospital, as a senior research manager. She developed and led the program, becoming its director in 2016. She is involved in the strategic planning, and develops collaborative relationship among universities, industry partners and CROs to support and advance patient-oriented research.

Pediatric Neurology & Neurosurgery

Dr. Farid Menaa is an inter-and multi-disciplinary professional with a worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging, and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity, and infectious diseases. He has more than 10 years of experience either in the academic, hospitals, or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology, and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated in over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menna worldwide collaborations, holistic point of view, and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.

Dr. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology

Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. Prof. Hegazi received his master’s degree in 1979, and his Ph.D. in 1981. Hegazi's research work has been focused lately on bee products and their therapeutic effects. Dr. Hegazi awards; First Class Decoration of Excellence, Egypt, 1995, The Senior Scientist Prize of National Research Center, Cairo, Egypt, 1996, The National Scientific Prize In Biological Sciences, Egypt, 1990, The Scientific Prize of The National Research Center, Cairo, Egypt, 1989, The Second Best Research Paper Award, International Congress of Propolis, Bones Aires, Argentina, 2000, Main Speaker Award,10 th Academic Conference, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006, 2 Bronze medals from The International Innovation Fair of the Middle East, Kuwait, 2007 Awarded of Ghazi Wad Allah Salon Prize, 2008. Awarded the Merit Aware of Medical Sciences, The National Research Center, 2016. Dr. Hegazi contributed Chairman of the National Committee for Microbiological Sciences (NCMS) in Egypt, Academy of Science and Technology, Egypt, from 2018. Hegazi organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He Conducted training courses on Clinical Microbiology at, National Research Center in 1979. He has 236 articles in national and international scientific journals. Editor in 48 journals, Referee in the 98 International Journals, Organizer of 114 International Symposium and conferences, His publications: 241 articles in national and international scientific journals, 9 books in the English language, and 13 books in the Arabic language. He has patent No. 28335at 11/12/2017. and registers for other 5

Microbiology and Immunology

Dr. Lu Qi obtained a medical degree in China and Ph.D. at Tufts University in the United States. He is now HCA Regents Distinguished Chair and Professor of Epidemiology in Tulane University School of Public Health and Tropical Medicine, Director of Tulane Personalized Health Institute, and Director of Tulane University Obesity Research Center. He is also an Adjunct Professor of Nutrition at Harvard T.H Chan School of Public Health. His research focuses on nutritional epidemiology, nutrigenomics, and nutrigenetics of obesity, diabetes, and cardiovascular diseases. As the Principal Investigator, he has led more than ten projects funded by NIH, American Heart Associations, and other funding agencies. He has published more than 370 scientific publications in peer- reviewed journals, including the high-impact journals such as N Engl J Med., JAMA, BMJ, Circulation, J Am Coll Cardiol., Eur Heart J., Nature, Nature Genetics and Nature Medicine. He has also written more than 10 book chapters and edited a textbook entitled ‘Gene-Environment Interactions and Human Diseases’. Dr. Qi’s current h-index is 94 (by May. 2021). Dr. Qi is a fellow of the American Heart Association (FAHA), American College of Nutrition (FACN), and The Obesity Society (FOS).

Nutritional epidemiology, Nutrigenomics and Nutrigenetics of obesity, Diabetes and Cardiovascular diseases.